Patent ID: 11969576
Assignee: TANDEM DIABETES CARE, INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 10:
11. An ambulatory infusion pump system, comprising:
a pump mechanism configured to facilitate delivery of insulin to a user;
a user interface;
a communications device adapted to receive glucose levels from a continuous glucose monitor;
a processor functionally linked to the pump mechanism, the user interface and the communications device, the processor configured to:
automatically calculate insulin doses with a closed loop delivery algorithm based on glucose levels received from the continuous glucose monitor;
deliver the calculated insulin doses to the user with the pump mechanism;
display a bolus programming feature for programming a bolus delivery of insulin to the user;
execute an auto-population risk mitigation procedure required to automatically populate a most recent glucose level received from the continuous glucose monitor into a blood glucose field of the bolus programming feature, the risk mitigation procedure requiring verification of one or more predefined conditions that aid in mitigating the risk of an inaccurate or invalid most recent glucose level; and
automatically populate the blood glucose field in the bolus programming feature with the most recent glucose level received from the continuous glucose monitor only if the auto-population risk mitigation procedure verifies the one or more predefined conditions including whether a rate of change of glucose levels received from the continuous glucose monitor satisfies a certain defined threshold.